Resumo
O rastreamento do câncer cervical foi considerado uma das estratégias clínicas preventivas mais bem-sucedidas. Ele foi associado a uma redução de 70% na mortalidade por câncer cervical em países desenvolvidos desde a introdução do teste de Papanicolau em 1941.[1][Figure caption and citation for the preceding image starts]: Erosão no colo uterino devido a um carcinoma cervical de baixo grauCentros de Controle e Prevenção de Doenças (CDC) [Citation ends].
American Congress of Obstetricians and Gynecologists: cervical cancer screening Opens in new window
National Cancer Institute: Pap and HIV testing Opens in new window
Detalhes
- Técnicas de amostragem cervical
- Citologia cervical
- teste de vírus do papiloma humano (HPV)
- Vacinação contra o papilomavírus humano (HPV)
- Colposcopia
- Rastreamento
Colaboradores
Autores
Richard T. Penson, MD, MRCP
Clinical Director
Medical Gynecologic Oncology
Division of Hematology Oncology
Massachusetts General Hospital
Boston
MA
Declarações
RTP has received institutional research funding from Array BioPharma Inc., AstraZeneca, Genentech, and Vascular Biogenics Ltd. RTP has been paid for participating in scientific advisory boards for: AbbVie, AstraZeneca, Clovis Oncology, Curio Science, Eisai Inc., Genentech, Janssen Oncology (J&J), Merck & Co., Mersana Therapeutics, Inc., NewLink Genetics, Nexus Global Group, Pieris Pharma Inc, Roche, Inc., Sutro Biopharma, Syndax Pharmaceuticals, Tesaro Inc., and Vascular Biogenics Ltd.
Marcela G. del Carmen, MD, MPH
Chief Medical Officer
Massachusetts General Physicians Organization
Division of Gynecologic-Oncology
Massachusetts General Hospital
Professor
Department of Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
Boston
MA
Declarações
MDC declares that she has no competing interests.
Revisores
Deirdre Lyons, MB, BCh, BAO, MRCOG
Consultant in Obstetrics & Gynaecology
Lead Clinician in Colposcopy
Imperial College Healthcare NHS Trust
London
UK
Declarações
DL declares that she has no competing interests.
Matejka Rebolj, PhD
Scientific Researcher
Centre for Epidemiology and Screening
Institute of Public Health
University of Copenhagen
Copenhagen
Denmark
Declarações
MR declares that she has no competing interests.
Shagufta Yasmeen, MD
Associate Professor
Department of Obstetrics and Gynecology
UC Davis Health System
Sacramento
CA
Declarações
SY declares that she has no competing interests.
O uso deste conteúdo está sujeito ao nosso aviso legal